CLINICAL_TRIALS
trial_result
· 2016-02-11
Clinical Trial Update: BATTLE Program: Sorafenib in Patients With NSCLC [Phase 2]
Summary
The BATTLE program's Phase 2 study of sorafenib in non-small cell lung cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-11